블로그
- FDA] FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Adv Tudriqev is indicated in combination with nivolumab for the treatment of adult patients with unresectable advanced cutaneous melanoma who experienced disease progression with a programmed death receptor-1 (
- FDA] FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Dise to reduce daily cornstarch intake as an adjunct to nutritional management in adults and pediatric patients 8 years of age and older with glycogen storage disease type Ia (GSDIa), a rare, inherited genetic disorder
- FDA] FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with R ages 8 through 17 years who have been recently diagnosed with Stage 3 type 1 diabetes (T1D). "The FDA recognizes the large unmet need in patients with type 1 diabetes," said Acting Asso.......
- 요통 환자를 위한 운동 치료(Exercises for patients with back pain) 서론 요통(low back pain)은 매우 흔한 임상 증상으로, 전체 인구에서 평생 유병률이 약 84%에 이른다. 급성 요통은 자연적으로 호전되는 경우가 많으나 재발률이 높고, 일부에서는 만성화되어 기능 저하와 장애를 유발할 수 있다. 국내에서도 장애보정 생존년수(disability-
- [국제169] KM Home-Visit Care for Cognitive Impairment: Retrospective study (2026, Scientific Reports) Clinical outcomes associated with Korean medicine home-visit care for patients with cognitive impairment with cognitive impairment (Global Deterioration Scale stages 2–5) assessed at baseline, 2 months, and
- [U.S. FDA] FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease Casgevy has been previously approved for the treatment of patients aged 12 years and older with SCD with “With today’s decision, pediatric patients as young as 2 years of age.......
-
성인 급성 설사에서 로페라미드, 언제 쓰고 언제 피해야 하나? – 발열·혈변·이질이 중요한 이유
For patients who want symptomatic therapy, the antimotility agent loperamide (Imodium) can be used cautiously in patients in whom fever is absent or low grade and the stools are not bloody.
- 성인 급성 설사에서 로페라미드, 언제 쓰고 언제 피해야 하나? – 발열·혈변·이질이 중요한 이유 For patients who want symptomatic therapy, the antimotility agent loperamide (Imodium) can be used cautiously in patients in whom fever is absent or low grade and the stools are not bloody.
- 하늘 아래 가장 쉬운 직독직해 27수능영어대비 기 수능관련 출제문- 한영교식 해석 239) Population with Dementia in Six [도표 데이터 복원 요약 표] Population with Dementia in Six European Countries per 1,000 Inhabitants in 2021 and in 2050 ① The graph above shows the number of dementia patients ① 위 그래프는 치매 환자 수를 보여줍니다 ② per 1,000
- 혈변·이질성 설사에서 항생제와 로페라미드를 함께 써도 될까? STEC는 반드시 예외입니다 We avoid antimotility agents in patients with clinical features suggestive of dysentery (fever, bloody
1 페이지
다음 →